Clinical trial · Observational
Association of Erectile Dysfunction With Neuropathic Pain, Disease Activity, and Functional Status in Male Patients With Axial Spondyloarthritis: A Cross-Sectional Observational Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
tudy Description Definitions Use this module to describe the study protocol. * Required * § Required if Study Start Date is on or after January 18, 2017 \[\*\] Conditionally required Brief Summary \* Use these resources to provide understandable information about this study to patients, families, and health care providers: Plain language checklist for Brief Summary Template for Brief Summary 5,000 characters allowed Detailed Description Avoid duplicating information that will be entered or uploaded elsewhere in the record. 32,000 characters allowed Save Changes Clear Unsaved Changes
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ankylosing Spondylitis | — | UNRESOLVED | — |
| Sexual Dysfunction | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Anti-TNF agents | Drug | — | UNRESOLVED |
| No Treatment (Healthy Controls) | Other | — | UNRESOLVED |
| NSAIDs | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- label
- Anti-TNF Therapy Group
- description
- Male patients with ankylosing spondylitis receiving anti-tumor necrosis factor therapy for at least 3 months.
- interventionNames
- Drug: Anti-TNF agents
- label
- NSAID Group
- description
- Male patients with ankylosing spondylitis receiving only nonsteroidal anti-inflammatory drugs for at least 3 months.
- interventionNames
- Drug: NSAIDs
- label
- Healthy Control Group
- description
- Age-matched healthy male volunteers without inflammatory rheumatic disease.
- interventionNames
- Other: No Treatment (Healthy Controls)
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: Male participants aged 18 years or older Diagnosis of ankylosing spondylitis according to accepted classification criteria (for patient groups) Receiving anti-TNF therapy or NSAIDs for at least 3 months (for patient groups) Ability to understand and complete study questionnaires Provided written informed consent For healthy control group: Male volunteers aged 18 years or older No history of inflammatory rheumatic disease Exclusion Criteria: Age under 18 years Use of anti-TNF therapy or NSAIDs for less than 3 months History of neurological disorders affecting sexual function Known severe psychiatric illness Use of medications known to significantly affect sexual function (e.g., antidepressants, antipsychotics) Refusal to participate or incomplete questionnaire data
References
Publications (0)
Data not yet available